Merck (MRK) Reports Election of Dr. Stephen Mayo to Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Marvell shares jump after giving Google warrants amid custom chip deal
Dr. Stephen Mayo Elected to Merck Board of Directors
February 1, 2021 6:45 AM ESTKENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Dr. Stephen Steve L. Mayo, professor, California Institute of Technology, will join the companys Board of Directors effective March 15, 2021. Dr. Mayo will stand for election with the companys other directors at Mercks Annual Meeting of Shareholders on May 25, 2021. With the addition of Dr. Mayo, the Merck board will consist of 14 members.
We are pleased to welcome Dr. Mayo to the Merck Board. He brings extensive scientific expertise, and we look... More
